CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Anika Therapeutics, Inc.  (ANIK)
Other Ticker:  
 
 

ANIK's Operating Income Growth by Quarter and Year

Anika Therapeutics,'s Operating Income results by quarter and year




ANIK Operating Income (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - 9.73 12.74 17.07
III Quarter September 8.57 10.27 13.69 13.14
II Quarter June 11.25 17.73 13.47 12.43
I Quarter March -7.83 8.01 10.71 5.50
FY   11.99 45.74 50.61 48.14



ANIK Operating Income third quarter 2018 Y/Y Growth Comment
Anika Therapeutics, Inc. reported decline in Operating Income in the third quarter by -16.52% to $ 8.57 millions, from the same quarter in 2017.
The contraction in the third quarter Anika Therapeutics, Inc.'s Operating Income compares unfavorably to the Company's average Operating Income growth of 2.12%.

Looking into third quarter results within Medical Equipment & Supplies industry 8 other companies have achieved higher Operating Income growth. While Anika Therapeutics, Inc.' s Operating Income fall of -16.52% ranks overall at the positon no. 420 in the third quarter.

Explain Operating Income growth


ANIK Operating Income ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - -23.63 % -25.37 % 41.19 %
III Quarter September -16.52 % -24.98 % 4.19 % 27.7 %
II Quarter June -36.55 % 31.63 % 8.37 % -18.22 %
I Quarter March - -25.21 % 94.73 % -76.96 %
FY   - -9.62 % 5.13 % -

Financial Statements
Anika Therapeutics,'s third quarter 2018 Operating Income $ 0.00 millions ANIK's Income Statement
Anika Therapeutics,'s third quarter 2017 Operating Income $ 0.00 millions Quarterly ANIK's Income Statement
New: More ANIK's historic Operating Income Growth >>


ANIK Operating Income (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - -5.26 % -6.94 % 29.91 %
III Quarter September -23.8 % -42.08 % 1.63 % 5.71 %
II Quarter June - 121.35 % 25.77 % 126 %
I Quarter March - -37.13 % -37.26 % -54.51 %
FY (Year on Year)   - -9.62 % 5.13 % -




Operating Income third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #9
Healthcare Sector #24
Overall #420

Operating Income Y/Y Growth Statistics
High Average Low
42.68 % 2.12 % -34.63 %
(March 31, 2014)   (Mar 31 2018)
Operating Income third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #9
Healthcare Sector #24
Overall #420
Operating Income Y/Y Growth Statistics
High Average Low
42.68 % 2.12 % -34.63 %
(March 31, 2014)   (Mar 31 2018)

Operating Income by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Anika Therapeutics,'s Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
185.74 % 18.94 % -55.55 %
(Dec 31 2012)  


ANIK's III. Quarter Q/Q Operating Income Comment
In the III. Quarter 2018 Anika Therapeutics, Inc. reported fall in Operating Income sequentially by -23.8% to $ 8.57 millions, from $ 11.25 millions released a quarter before.

But that's not important problem, as Anika Therapeutics,'s Operating Income always seem to dip in the III. Quarter Rebecca Lee, Medical Equipment & Supplies industry contributor located in Dublin noted.

Within Medical Equipment & Supplies industry 7 other companies have achieved higher Operating Income quarter on quarter growth. While Anika Therapeutics,'s Operating Income growth quarter on quarter, overall rank is 366.


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #24
Overall #366
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #24
Overall #366
Operating Income Q/Q Growth Statistics
High Average Low
185.74 % 18.94 % -55.55 %
(Dec 31 2012)  


ANIK's III. Quarter Q/Q Operating Income Comment
In the III. Quarter 2018 Anika Therapeutics, Inc. disclosed fall in Operating Income from the previous quarter by -23.8% to $ 8.57 millions, from $ 11.25 millions achived in the previous qaurter.

If you analyse present slump at the III. Quarter, you should assume, that usually III. Quarter performance emerge softer relative to the second quarter, Rebecca Lee, Medical Equipment & Supplies industry contributor located in Dublin added.

Within Medical Equipment & Supplies industry 7 other companies have achieved higher Operating Income quarter on quarter growth. While Anika Therapeutics,'s Operating Income growth quarter on quarter, overall rank is 366.


Anika Therapeutics,'s 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
Cumulative Operating Income 12 Months Ending $ 21.72 $ 23.41 $ 29.89 $ 45.73 $ 48.74
Y / Y Operating Income Growth (TTM) -55.45 % -55.12 % -37.6 % -9.64 % -11.27 %
Year on Year Operating Income Growth Overall Ranking # 425 # 1823 # 2013 # 1335 # 359
Seqeuential Operating Income Change (TTM) -7.24 % -21.68 % -34.63 % -6.18 % -6.56 %
Seq. Operating Income Growth (TTM) Overall Ranking # 420 # 1894 # 2315 # 1747 # 1475




Cumulative Operating Income growth Comment
Anika Therapeutics,'s cumulative 12 months Operating Income continue to drop, but on the faster rate at -55.45% year on year, at Sep 30 2018 compare to the -55.12% decrease at Jun 30 2018. If the Anika Therapeutics,'s fiscal year would end at Sep 30 2018, annual Operating Income would be $22 millions.

Within the Healthcare sector 28 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 425, from total ranking in previous quarter at 1823.

Operating Income TTM Q/Q Growth Statistics
High Average Low
42.68 %
2.12 %
-34.63 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 9
Healthcare Sector # 29
Overall # 425

Operating Income TTM Y/Y Growth Statistics
High Average Low
172.63 %
13.97 %
-55.45 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 24
S&P 500 # 420
Cumulative Operating Income growth Comment
Anika Therapeutics,'s cumulative 12 months Operating Income continue to drop, but on the faster rate at -55.45% year on year, at Sep 30 2018 compare to the -55.12% decrease at Jun 30 2018. If the Anika Therapeutics,'s fiscal year would end at Sep 30 2018, annual Operating Income would be $22 millions.

Within the Healthcare sector 28 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 425, from total ranking in previous quarter at 1823.

Operating Income TTM Q/Q Growth Statistics
High Average Low
42.68 %
2.12 %
-34.63 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 9
Healthcare Sector # 29
Overall # 425

Operating Income TTM Y/Y Growth Statistics
High Average Low
172.63 %
13.97 %
-55.45 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 24
S&P 500 # 420




Other Operating Income Growth
Medical Equipment & Supplies Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
ANIK's Operating Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for ANIK's Competitors
Operating Income Growth for Anika Therapeutics,'s Suppliers
Operating Income Growth for ANIK's Customers

You may also want to know
ANIK's Annual Growth Rates ANIK's Profitability Ratios ANIK's Asset Turnover Ratio ANIK's Dividend Growth
ANIK's Roe ANIK's Valuation Ratios ANIK's Financial Strength Ratios ANIK's Dividend Payout Ratio
ANIK's Roa ANIK's Inventory Turnover Ratio ANIK's Growth Rates ANIK's Dividend Comparisons



Companies with similar Operating Income drop for the quarter ending Sep 30 2018 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2018
Universal Health Services Inc -0.06 %$ -0.057 millions
Bio-techne Corp -1.03 %$ -1.030 millions
Msa Safety Incorporated -1.51 %$ -1.512 millions
Healthcare Services Group Inc -1.70 %$ -1.702 millions
Zynex Inc -3.92 %$ -3.918 millions
Amgen Inc. -4.76 %$ -4.756 millions
West Pharmaceutical Services Inc -4.85 %$ -4.851 millions
Psychemedics Corp -5.02 %$ -5.018 millions
Lifevantage Corp -5.29 %$ -5.293 millions
Utah Medical Products Inc -5.92 %$ -5.920 millions
Atrion Corp -6.29 %$ -6.290 millions
Prestige Consumer Healthcare Inc. -6.87 %$ -6.871 millions
Djo Finance Llc -8.67 %$ -8.673 millions
Lemaitre Vascular Inc -8.71 %$ -8.708 millions
Hologic Inc -9.41 %$ -9.415 millions
Magellan Health Inc -9.92 %$ -9.920 millions
Artemis Therapeutics, Inc. -10.57 %$ -10.573 millions
Hca Healthcare, Inc. -13.47 %$ -13.472 millions
Mednax, Inc. -13.66 %$ -13.660 millions
Conmed Corp -14.46 %$ -14.462 millions
Anika Therapeutics, Inc. -16.52 %$ -16.516 millions
Community Health Systems Inc -17.78 %$ -17.778 millions
Standard Diversified Inc. -18.14 %$ -18.140 millions
Meridian Bioscience Inc -19.27 %$ -19.269 millions
Henry Schein Inc -22.30 %$ -22.300 millions
Eagle Pharmaceuticals, Inc. -26.24 %$ -26.244 millions
Owens & Minor Inc -28.02 %$ -28.021 millions
Gilead Sciences Inc -31.19 %$ -31.191 millions
Mettler Toledo International Inc -31.52 %$ -31.518 millions
Lifepoint Health, Inc. -35.00 %$ -35.004 millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

REED's Profile

Stock Price

REED's Financials

Business Description

Fundamentals

Charts & Quotes

REED's News

Suppliers

REED's Competitors

Customers & Markets

Economic Indicators

REED's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071